agilon health Announces Pricing of Initial Public Offering

Rhea-AI Summary

agilon health has priced its initial public offering (IPO) at $23.00 per share, offering 46,600,000 shares for a total gross proceeds of approximately $1,072 million. The shares will start trading on the New York Stock Exchange under the ticker symbol AGL on April 15, 2021, with the expected closing date on April 19, 2021. The underwriters have a 30-day option to purchase an additional 6,990,000 shares. The offering is managed by J.P. Morgan, Goldman Sachs, and BofA Securities, among others.

Positive

• IPO pricing at $23.00 per share, raising approximately $1,072 million.
• Additional share option of 6,990,000 shares could enhance capital.
• Expansion to 17 local communities indicates growth potential.

Negative

• None.

agilon health, inc. (“agilon health”), which partners with primary care physicians to unlock value-based healthcare delivery, announced the pricing of its initial public offering of 46,600,000 shares of its common stock at a public offering price of $23.00. All of the shares of common stock are being offered by agilon health. The gross proceeds of the offering, before deducting underwriting discounts and commissions and other expenses payable by agilon health, are expected to be approximately $1,072 million. agilon health has granted the underwriters a 30-day option to purchase up to an additional 6,990,000 shares of its common stock at the initial public offering price, less underwriting discounts and commissions.

The shares are expected to begin trading on the New York Stock Exchange on April 15, under the ticker symbol AGL. The offering is expected to close on April 19, 2021, subject to customary closing conditions.

J.P. Morgan, Goldman Sachs & Co. LLC, and BofA Securities are acting as lead book-running managers for the proposed offering. Deutsche Bank Securities, Wells Fargo Securities, William Blair, Truist Securities, and Nomura are acting as additional book-running managers.

A registration statement relating to these securities was declared effective by the U.S. Securities and Exchange Commission (“SEC”) on April 14, 2021. The offering is being made only by means of a prospectus. Copies of the preliminary prospectus, when available, may be obtained from: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (866) 803-9204, or by email at prospectus-eq_fi@jpmchase.com; or Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing prospectus-ny@ny.email.gs.com; or BofA Securities, Attention: Prospectus Department, NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, NC 28255-0001, or by email at dg.prospectus_requests@bofa.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.

About agilon health

agilon health is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. agilon health enables physicians to create their own Medicare-centric globally capitated line of business. The agilon Total Care Model is powered by our purpose-built platform and enabled through a growing national network of like-minded physician partners. With agilon, physicians are freed from the constraints of the transactional fee-for-service reimbursement model and are able to practice team-based, coordinated care to serve the individual needs of their senior patients and to transition to a sustainable and predictable, long-term business model. The rapidly growing appeal of the agilon platform, partnership model and network of leading community-based physicians has allowed us to expand to 17 local communities with 16 anchor physician groups, as well as a network of physicians across Hawaii, in fewer than five years.

Cautionary Note Regarding Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the proposed initial public offering. No assurance can be given that the offering discussed above will be completed on the terms described, or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of agilon health, including those set forth in the Risk Factors section of the registration statement and the preliminary prospectus included therein. Copies are available on the SEC’s website at www.sec.gov. agilon health undertakes no obligation to update these statements for revisions or changes after the date of this press release, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210414005921/en/

FAQ

What is the share price for agilon health's IPO?

The share price for agilon health's IPO is set at $23.00.

When will agilon health start trading on the NYSE?

agilon health shares are expected to begin trading on the NYSE on April 15, 2021.

How many shares are being offered in agilon health's IPO?

agilon health is offering 46,600,000 shares in its IPO.

What are the expected gross proceeds from agilon health's IPO?

The expected gross proceeds from the IPO are approximately $1,072 million.

Who are the lead managers for agilon health's IPO?

The lead managers for agilon health's IPO are J.P. Morgan, Goldman Sachs, and BofA Securities.